ISPOR Launches “HEOR Explained” Microsite

Published Dec 10, 2024
New Site Explores How Health Economics and Outcomes Research Helps Inform and Improve Healthcare Decisions


Lawrenceville, NJ, USA
—December 10, 2024—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.

Healthcare systems around the world are facing a number of momentous issues that make it challenging to identify which healthcare decisions will lead to the best health outcomes for patients. Strained budgets, the growth of innovative new therapy options, and rising costs all contribute to the increasing complexity of healthcare decision making. The field of HEOR can provide healthcare decision makers with a powerful tool to improve healthcare decisions and to potentially transform healthcare systems.

HEOR Explained is an exciting new initiative designed to help anyone with an interest in healthcare to better understand how the field of HEOR can help improve healthcare decisions and the lives of patients,” stated ISPOR CEO Rob Abbott. “As healthcare decision making becomes increasingly complex, HEOR insights can help cut through the noise to inform the best possible choices for patients. The HEOR Explained microsite, and initiatives like this, are in service of our vision of a world where healthcare is accessible, effective, efficient, and affordable for all.”

Access to HEOR Explained and additional resources include:
HEOR Explained Microsite
| Top 10 HEOR Trends Report | ISPOR Strategic Plan 2030 | HEOR News Desk

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×